USP39 and EphA2 expression in breast cancer before and after trastuzumab treatment and their correlation with the pathological characteristics of tumor
Objective: To study the USP39 and EphA2 expression in breast cancer before and after trastuzumab treatment and their correlation with the pathological characteristics of tumor. Methods: Breast cancer tissues before and after trastuzumab treatment between May 2013 and September 2016 were collected...
Main Authors: | Li-Ping Shen1, Kun Wang2 |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2017-05-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/201710/30.pdf |
Similar Items
-
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
by: Malgorzata Gajdzis, et al.
Published: (2020-09-01) -
Targeting EphA2 in cancer
by: Ta Xiao, et al.
Published: (2020-08-01) -
A novel pH-dependent membrane peptide that binds to EphA2 and inhibits cell migration
by: Daiane S Alves, et al.
Published: (2018-09-01) -
Role of EphA4 in Mediating Motor Neuron Death in MND
by: Jing Zhao, et al.
Published: (2021-08-01) -
Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors
by: Nikki Cheng, et al.
Published: (2003-09-01)